THC · Tenet Healthcare Corp
$233.20
+34.18 (+17.17%)
At close · Jul 24
Market Cap
$20.09B
Shares
86.14M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-23 | — | |
| 8-K | 2026-05-29 | 2026-05-27 | |
| 8-K | 2026-04-30 | — | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| DEF 14A | 2026-04-16 | 2026-05-27 | |
| 8-K | 2026-04-10 | 2026-04-09 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-30 | 2026-03-25 | |
| 10-K | 2026-02-17 | 2025-12-31 | |
| 8-K | 2026-02-11 | — | |
| 8-K | 2026-02-02 | 2026-01-27 | |
| 8-K | 2025-11-24 | 2025-11-21 | |
| 8-K | 2025-11-18 | — | |
| 8-K | 2025-11-05 | 2025-11-04 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-28 | — | |
| 10-Q | 2025-10-28 | 2025-09-30 | |
| 10-Q | 2025-07-30 | 2025-06-30 | |
| 8-K | 2025-07-22 | — | |
| 8-K | 2025-06-05 | 2025-05-30 | |
| 8-K | 2025-05-27 | 2025-05-22 | |
| 10-Q | 2025-04-29 | 2025-03-31 | |
| 8-K | 2025-04-29 | — | |
| DEF 14A | 2025-04-11 | 2025-05-22 | |
| 10-K | 2025-02-18 | 2024-12-31 | |
| 8-K | 2025-02-12 | — | |
| 8-K | 2025-01-24 | 2025-01-23 | |
| 10-Q | 2024-10-29 | 2024-09-30 | |
| 8-K | 2024-10-29 | — | |
| 8-K | 2024-08-05 | — | |
| 10-Q | 2024-07-30 | 2024-06-30 | |
| 8-K | 2024-07-24 | — | |
| 8-K | 2024-05-23 | 2024-05-22 | |
| 8-K | 2024-04-30 | — | |
| 10-Q | 2024-04-30 | 2024-03-31 | |
| DEF 14A | 2024-04-12 | 2024-05-22 | |
| 8-K | 2024-04-01 | — | |
| 8-K | 2024-02-29 | — | |
| 8-K | 2024-02-16 | — | |
| 10-K | 2024-02-16 | 2023-12-31 | |
| 8-K | 2024-02-08 | — | |
| 8-K | 2024-02-01 | — | |
| 8-K | 2024-02-01 | — | |
| 8-K | 2023-12-13 | 2023-12-11 | |
| 8-K | 2023-11-17 | — | |
| 8-K | 2023-10-30 | — | |
| 10-Q | 2023-10-30 | 2023-09-30 | |
| 8-K | 2023-09-08 | 2023-09-07 | |
| 8-K/A | 2023-08-11 | 2023-01-19 | |
| 8-K | 2023-08-10 | 2023-08-09 |
Showing 1–50 of 131 filings
Key facts
CIK
70318
CUSIP
88033G407
13F (30d)
143 filings
142 filers
Visit website
Investor relations